Radonjić, Nevena V. https://orcid.org/0000-0002-1272-2284
Hess, Jonathan L. https://orcid.org/0000-0001-8406-632X
Rovira, Paula https://orcid.org/0000-0003-2177-8412
Andreassen, Ole
Buitelaar, Jan K. https://orcid.org/0000-0001-8288-7757
Ching, Christopher R. K.
Franke, Barbara https://orcid.org/0000-0003-4375-6572
Hoogman, Martine
Jahanshad, Neda https://orcid.org/0000-0003-4401-8950
McDonald, Carrie
Schmaal, Lianne https://orcid.org/0000-0001-9822-048X
Sisodiya, Sanjay M.
Stein, Dan J. https://orcid.org/0000-0001-7218-7810
van den Heuvel, Odile A.
van Erp, Theo G. M. https://orcid.org/0000-0002-2465-2797
van Rooij, Daan
Veltman, Dick J.
Thompson, Paul
Faraone, Stephen V. https://orcid.org/0000-0002-9217-3982
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302, 667302)
Article History
Received: 29 May 2020
Revised: 7 December 2020
Accepted: 11 December 2020
First Online: 17 January 2021
Compliance with ethical standards
:
: OA has received speaker’s honorarium from Lundbeck and is a consultant to HealthLytix. In the past year, SVF received income, potential income, travel expenses continuing education support, and/or research support from Tris, Otsuka, Arbor, Ironshore, Shire, Akili Interactive Labs, Enzymotec, Sunovion, Supernus and Genomind. With his institution, he has US patent US20130217707 A1 for the use of sodium–hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is Program Director of . BF received educational speaking fees from Medice. All other authors declare no conflict of interest.